3Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(Suppll ) : 116S.
4Doit CP.In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus Pneumoniae isolated from children with meningitis[J].Antimicrob Agents Chemother,1994,38(11):2655-2659.
5Cohen R,Barre J,Varon E.A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin[J].Pathol Biol Paris,1992,40(8):831-844.
6Ishii T,Takayama Y,Takase Y,et al.Antibacteriological activities of arbekacin and vancomycin against strains of MRSA[J].Jpn J Antibiot,1994,47(6):647-654.
8Shlaes DM,Shlaes JH,Vimcent S,et al.Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex[J].Antimicrob Agents Chemotherapy,1993,37(11):2432-2437.
9Lim LM, Ly N, Anderson D, et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing [J]. Pharmacotherapy, 2010, 30(12): 1279-1291.
10Michalopoulos AS, Karatza DC. Multidrug-resistant Gram- negative infections: the use of colistin [J]. Expert Rev Anti Infect Ther, 2010, 8(9): 1009-1017.
